Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus Extension Study in Renal Transplant Recipients
NCT00531440Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2001
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in kidney transplant rejection, sponsored by Novartis. Started Nov 2001; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00531440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531440.